William F. Waverczak

Mutations of the 22- and 27-kD zein promoters affect transactivation by the Opaque-2 protein.

Takashi Ueda, William F. Waverczak, Kathleen Ward et al. · The Plant Cell · 1992 · 89 citations · Full text

Transcriptional Regulation, Signal Transduction, Protein Expression +14

A Titrate-to-Goal Study of Switching Patients Uncontrolled on Antihypertensive Monotherapy to Fixed-Dose Combinations of Amlodipine and Olmesartan Medoxomil ± Hydrochlorothiazide

Willa A. Hsueh, Shawna D. Nesbitt, Thomas J. Littlejohn et al. · Journal of Clinical Hypertension · 2011 · 83 citations · Full text

Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study

Henry Punzi, Joel M. Neutel, Dean J. Kereiakes et al. · Therapeutic Advances in Cardiovascular Disease · 2010 · 42 citations

The Effects of an Olmesartan Medoxomil–Based Treatment Algorithm on 24‐Hour Blood Pressure Levels in Elderly Patients Aged 65 and Older

Dean J. Kereiakes, Joel Neutel, Kathy A. Stoakes et al. · Journal of Clinical Hypertension · 2009 · 34 citations · Full text

Hypertension, Aging, Elderly Patients +17

Results of an Olmesartan Medoxomil–Based Treatment Regimen in Hypertensive Patients

Suzanne Oparil, Steven G. Chrysant, Dean J. Kereiakes et al. · Journal of Clinical Hypertension · 2008 · 26 citations · Full text